Document is current
Any future updates will be listed below
-
Authors
Zeng, Yibin
Lin, Feifei
Li, Hui
Wu, Qian
Zhang, Ting
Chen, Jianshu
Wang, Yifan
Lin, Jing
Tang, Lirui
Chen, Yu
Lin, Peicheng
Li, Jinluan
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Fujian Province (2024J08272)
Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy (2020Y2012, 2020Y2012, 2020Y2012, 2020Y2012)
Fujian Research and Training Grants for Youth and Middle-aged Leaders in Healthcare (2022)
- License Information
-
More Information
Article History
Received: 9 August 2024
Accepted: 8 August 2025
First Online: 11 August 2025
Declarations
:
: This is a retrospective study and which was conducted in accordance with the 1964 Declaration of Helsinki and International Conference on Harmonization of Good Clinical Practice Tripartite guidelines. This clinical study was approved by the Ethics Committee of Fujian Cancer Hospital Fuzhou, China (No. K2023-030-01). Due to the retrospective nature of the study, Institutional Review Board waived the need of obtaining informed consent.
: The authors declare no competing interests.
